StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingNov 12, 2026, 02:42 PM

Genmab Board Members Sell Shares Worth Over DKK 3.4M

AI Summary

Genmab A/S disclosed transactions made by its managerial employees and closely associated persons in accordance with market abuse regulations. Martin Schultz and Mijke Zachariasse, both members of the Board of Directors, reported the sale of Genmab A/S shares. Schultz sold 617 shares, and Zachariasse sold 351 shares, both at a price of DKK 3,540.87 per share on November 12, 2026.

Key Highlights

  • Martin Schultz, Member of the Board of Directors, sold 617 Genmab A/S shares at DKK 3,540.87 each.
  • Mijke Zachariasse, Member of the Board of Directors, sold 351 Genmab A/S shares at DKK 3,540.87 each.
  • Total sale volume by these two board members was 968 shares at an average price of DKK 3,540.87.